Ensuring access to vaccines and related products =>> Managing process for country support from Vaccine Fund =>>
All eligible countries that qualify and are interested in GAVI/VF support for ISS, new vaccines and injection safety, will have applied and will have been approved based on satisfactory proposals and progress reports.
||Achievement of overall target
||• Twelve country proposals were reviewed for 17 requests of support.
• The number of reviews for country proposals was increased (from one to two), to accommodate additional requests from countries.
• Two monitoring reviews were held as planned.
• Now a total of 71 out of 75 eligible countries have been approved for support.
Responsible entity: Secretariat
Completed by: December 2005
Total budget: $4,743,057
Total budget includes Secretariat's salaries: $2,963,707
Target description and how it will help reach GAVI milestones
GAVI Board and VF Executive Committee take decisions on the recommendations of the Independent Review Committee after two reviews of country proposals and one review of Progress reports every year. Decisions are based on countries' requests of support for ISS, new vaccines and Injection Safety and on countries' reports about implementation of GAVI/VF supported activities. These decisions will have an effect on countries' capacity and partners' collaboration to prevent children deaths through immunization and to move towards achievement of first three GAVI milestones. These decisions will have substantive financial implications affecting future funding by interested donors. Inappropriate implementation of the reviews would lead to a significant waste of resources for the Alliance and for the countries involved. Ineffective management of the review process would negatively affect the quality of GAVI/VF support and eventually its credibility.
ACCESS, HEPB & HIB MILESTONES: Review of country proposals enables countries to access GAVI/VF resources to improve their immunization services.
Justification for selection of activities
The process developed by the Secretariat to solicit and review proposals and make recommendations to the GAVI Board has worked well; there is no reason to consider major changes in the coming biennium.
|Activities||Budget||Coordinating partner/ support partners||Expected outcomes|
|Organize reviews of country proposals and progress reports for 2004||$514,675||Secretariat WHO UNICEF VF||By the end of 2004, the Independent Review Committee will have reviewed and GAVI Board will have approved|
• 68 Progress Reports,
• 2 requests for infrastructure support (ISS)
• 13 requests for injection safety (INS)
• 2 requests for yellow fever,
• 10 requests for hepB
• 5 requests for Hib.
|Organize reviews of country proposals and of progress reports for 2005||$664,675||Secretariat WHO UNICEF VF ||By the end of 2005, the Independent Review Committee will have reviewed and GAVI Board will have approved|
• 72 Progress Reports,
• 1 request for infrastructure support (ISS)
• 10 requests for injection safety (INS)
• 2 requests for yellow fever,
• 13 requests for hepB
• 3 requests for Hib.
|Support to countries to improve quality of reporting||$600,000||Secretariat, WHO, UNICEF||• By the end of 2005 the reporting and information received from all countries is of acceptable quality|
Detailed information on activities
Under the budget column of "additional funding request" we have estimated $ 125,000 in 2004 and $ 131,250 in 2005 for each review. In 2004 there will be one proposal review and 2 progress report reviews; in 2005 there will be 2 proposal reviews and 2 progress report reviews. We have also estimated for each year $55,680 for 3 pre-assessments and $ 83,995 for follow-up of review results (estimated 10 country visits by regional staff) carried out by WHO. We have estimated that 20 countries will submit applications in 2004 and 15 countries in 2005 and that 68 countries will submit an Inception/Progress Report in 2004 and 72 in 2005. Related but outside the WP budget we have estimated that a country spends an average of $ 20,000 to prepare and submit the proposals for support and $ 5,000 to prepare and submit the Progress Report, including the cost for Technical Assistance and the ICC meetings.
The concerns of the IRC regarding the quality of reporting will be addressed through partner support to countries. The modalities of this support will be further discussed.
Targets by priority area
Ensuring access to vaccines and related products
==>> Procurement/Supply of existing products
==>> Development and introduction of new, near-term products
==>> Managing process for country support from Vaccine Fund
• All eligible countries that qualify and are interested in GAVI/VF support for ISS, new vaccines and injection safety, will have applied and will have been approved based on satisfactory proposals and progress reports.
• External Data Quality Audits (DQAs) conducted in relevant countries.
• Coverage surveys carried out when needed for allocation of performance-based grants
Securing long-term financing
==>> Financial sustainability
==>> Recapitalization of The Vaccine Fund
Strategic planning & monitoring
==>> Setting priorities
==>> Monitoring progress
==>> Alliance coordination
Strengthening service delivery
==>> Health information and monitoring systems
==>> Contributing to alleviation of system-wide barriers
==>> Enhanced efforts in large population countries